Danish Pharmacovigilance Update, 17 November 2011

01 December 2011

In this issue of Danish Pharmacovigilance Update:

  • Domperidone (Motilium® etc.) and potential risk of cardiac disorders
  • The European Medicines Agency, EMA, recommends a lower dose of the antidepressant citalopram
  • Pradaxa® – new recommendations for assessment of renal function
  • Antiepileptics and the risk of bone disorders
  • No evidence of causal relationship between treatment with angiotensin II antagonists and increased risk of developing cancer
  • Xigris® for treatment of adults with severe sepsis and multiple organ failure to be withdrawn
  • Danish Pharmacovigilance Update celebrates 2-year anniversary

Download the newsletter in the box to the right.

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.